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Methods: Human osteoarthritic chondrocytes were culture with or
without Interleukin-1B in the presence or absence of Diacerhein
or Rhein for 24 hours. Nitric oxide was estimated via Nitrite quan-
tiﬁcation by the Griess reagent and apoptosis was investigated by
using the Vibrant Apoptosis kit (Molecular Probes). The localisa-
tion of FoxO1, FoxO3a, FoxO4 and protein p65 (a member of the
nuclear factor-kappaB family) was investigated by ﬂuorescence
confocal microscopy. FoxO1, FoxO3a and FoxO4 expression was
determinated by Western blotting.
Results: Diacerhein and Rhein reduced IL-1B - induced NO in-
crease and p65 nuclear localisation as previously shown. In control
cells, FoxO transcription factors were localisated in the cytoplasm.
In the presence of Diacerhein or Rhein, FoxO transcription factors
were found to have nuclear localisation whereas they are in the
cytoplasm in the presence of IL-1B. When Diacerhein or Rhein
are added to the culture medium containing IL-1B, the localisation
of FoxO transcription factors changes and become nuclear. No
signiﬁcant changes were observed on FoxO proteins expression
among the samples of the study.
Conclusions: Previous studies have shown that Diacerein and
its active metabolite reduce the IL-1β deleterious effects on os-
teoarthritis (OA) cartilage through inhibition of the expression of
degrading enzymes. This study presents evidence of the involve-
ment of FoxO transcription factors on diacerein mode of action.
It could explain the downregulated proliferation and the increased
p27 expression observed on human osteoarthritic chondrocytes in
the presence of Rhein recently found by other groups.
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Purpose: Articular chondrocytes are exposed in vivo to the con-
tinually changing osmotic environment and thus require volume
regulatory mechanisms. The present study was designed to in-
vestigate i) the functional role of the swelling-activated Cl- current
(ICl,swell) in the regulatory volume decrease (RVD) and ii) the regu-
latory role of tyrosine phosphorylation in ICl,swell, in isolated rabbit
articular chondrocytes.
Methods: Rabbit cartilages were collected from bilateral knee, hip
and glenohumeral joints of male animals weighing 2.0 to 3.0 kg.
The cartilage was dissected into slices and cultured in DMEM
for 1-3 days. On the day of experiments, chondrocytes were
isolated by enzymatic digestion. Whole-cell membrane current
was recorded during exposure to isosmotic (300 mOsm) and
hyposmotic (210 mOsm) external solutions under conditions where
Na+, K+ and Ca2+ currents were minimized. To measure of cell
volume, isolated chondrocytes were allowed to settle onto the
experimental chamber mounted on an inverted microscope. The
chamber was continuously perfused with bathing solutions at the
rate of 2-3 ml min-1. Microscope images of chondrocytes were
recorded with a CCD digital camera equipped with DS-L2 control
unit at 2560×1592 resolution every 1 min, and the area of the cell
image was measured using Image-J public domain software.
Results: The isolated chondrocytes exhibited a RVD during sus-
tained exposure to hyposmotic solution, which was mostly in-
hibited by the ICl,swell blocker DCPIB (4-(2-butyl-6,7-dichloro-2-
cyclopentyl-indan-1-on-5-yl) oxobutyric acid) at 20 μM. Exposure
to a hyposmotic solution activated ICl,swell, which was also largely
inhibited by 20 μM DCPIB. Activation of ICl,swell was signiﬁcantly
reduced by the protein tyrosine kinase (PTK) inhibitor genistein (30
μM) but was scarcely affected by its inactive analogue daidzein
(30 μM). Intracellular application of protein tyrosine phosphatase
(PTP) inhibitor sodium orthovanadate (250 and 500 μM) resulted
in a gradual activation of a Cl- current even in isosmotic solu-
tions. This Cl- current was almost completely inhibited by DIDS
(4,4’-diisothiocyanatostilbene-2,2’-disulphonic acid, 500 μM) and
was also largely suppressed by exposure to hyperosmotic solu-
tion, thus indicating a close similarity to ICl,swell. Pretreatment of
chondrocytes with genistein signiﬁcantly prevented the activation
of the Cl- current by sodium orthovanadate, suggesting that the
basal activity of endogenous PTK is required for the activation of
this Cl- current.
Conclusions: Our results provide evidence to indicate that acti-
vation of ICl,swell is involved in RVD and is facilitated by tyrosine
phosphorylation in isolated rabbit chondrocytes.
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Objectives: To study the effects of Quantum Magnetic Resonance
(QMR) beams on clinical and functional parameters and cartilage
thickness of osteoarthritic knee joints.
Background of QMR Therapy: Quantum Magnetic Resonance
Therapy™ utilizes highly complex quantum electromagnetic beams
in the sub-radio and near-radio frequency spectrum. The beams
can be precisely controlled and focused onto tissues therein
generating streaming voltage potentials. In osteoarthritis, this ﬂow
in the joint causes forced movement of hydrogen protons in the
extra cellular matrix (ECM) due to the alteration in QMR spin in
the hydrogen atoms and stimulates the chondrocytes.
Methods: After the publication (2004) of the results of a pilot
study on the effect of QMR on 35 patients with osteoarthritis,
300 more patients with osteoarthritis have been treated with QMR
as a follow up study. The patients were assessed on the basis
of well-established internationally recognized knee society rating
system and scores prior to immediately after treatment and further
after three months were computed. In addition, MRI of the knees
was done using standard protocol before and after three months
of treatment with a view to measure the changes in the cartilage
thickness in the knee joints.
Results: By the end of the treatment the patients could walk up
to ﬁve times more than before treatment without any difﬁculty. MRI
showed a remarkable increase in the thickness of the cartilage in
the knee joint at three months, from 0.67mm (±0.02) pre-treatment
to 3.25mm (±0.74) in left knee, and 0.66mm (±0.02) to 2.71mm
(±0.58) in the right knee joint (p<0.001).
Conclusions: QMR Therapy™ has now been successfully em-
ployed to induce mitotic activity in the fully differentiated chon-
drocytes. It is also seen that therapeutic exposure to quantum
magnetic resonance beams is effective in ameliorating the signs
and symptoms of OA, and inducing regenerative activity in the
chondrocytes as evidenced by an increase in the cartilage thick-
ness. QMR Therapy™ is a method for regeneration of cartilage
and is effective for treatment of osteoarthritis of the knee joint.
